Disclosure regarding the invitation to shareholders for the EGM Regulatory DisclosuresBy adminJune 18, 2023
Disclosure regarding the invitation to shareholders for the EGM Regulatory DisclosuresBy adminJune 18, 2023
Disclosure regarding Rameda acquiring a selection of pharmaceutical products belong to diabetes and cholesterol treatment drugs Regulatory DisclosuresBy adminJune 1, 2023
Disclosure regarding the invitation to shareholders for the AGM Regulatory DisclosuresBy adminMarch 9, 2023